Cargando…
Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women
AIM OF STUDY: The aim of this study is to evaluate antihypertensive drug prescription patterns, rationality and adherence to Joint National Committee (JNC-7) hypertension (HT) treatment recommendations among Indian postmenopausal women (PMW). MATERIALS AND METHODS: An observational and cross-section...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071649/ https://www.ncbi.nlm.nih.gov/pubmed/24970986 http://dx.doi.org/10.4103/0976-7800.133994 |
_version_ | 1782322828420317184 |
---|---|
author | Tandon, Vishal R. Sharma, Sudhaa Mahajan, Shagun Mahajan, Annil Khajuria, Vijay Mahajan, Vivek Prakash, Chander |
author_facet | Tandon, Vishal R. Sharma, Sudhaa Mahajan, Shagun Mahajan, Annil Khajuria, Vijay Mahajan, Vivek Prakash, Chander |
author_sort | Tandon, Vishal R. |
collection | PubMed |
description | AIM OF STUDY: The aim of this study is to evaluate antihypertensive drug prescription patterns, rationality and adherence to Joint National Committee (JNC-7) hypertension (HT) treatment recommendations among Indian postmenopausal women (PMW). MATERIALS AND METHODS: An observational and cross-sectional prospective prescription audit study was carried over a period of 1 year. A total of 500 prescriptions prescribed to PMW for diagnosed HT, were identified for one point analysis. Drug prescription patterns/trends, and their adherence to JNC-7 report as well as rationality using WHO guide to good prescribing was assessed. RESULTS: In the monotherapy, category angiotensin receptor blockers (ARBs) accounted (24.8%), calcium channel blockers (CCBs) (19.4%), angiotensin converting enzyme inhibitors (ACEIs) (11%), beta blockers (BBs) (2.8%), and diuretics (2%) of the total prescription. Individually, amlodipine was maximally prescribed in 16.4%. 31.6% had double combination, whereas 2.2% and 1% had triple and four drug combinations, respectively. About 3.6% of the prescription contained antihypertensive combination along with other class of drug. ARBs + diuretic were observed in 11%, CCBs + BB 10% and ACEI + diuretic in 2.6% of the total prescriptions. Among the combination therapy amlodipine + atenolol (8.4%), telmisartan + hydrochlorothiazide (6%) and losartan + hydrochlorothiazide (4.4%) were maximally prescribed. 84.21% (P < 0.001) of the prescription showed nonadherence as per recommendations for pre-HT. 100% and 43.25% adherence rates were noticed for Stage 1 HT (P < 0.001) and Stage 2 HT (P > 0.05) patients. CONCLUSION: Antihypertensive prescription trends largely adhere to existing guidelines and are rational except polypharmacy, generic and fixed dose combinations prescribing, were some of the common pharmacologically considered irrationality noticed. |
format | Online Article Text |
id | pubmed-4071649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40716492014-06-26 Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women Tandon, Vishal R. Sharma, Sudhaa Mahajan, Shagun Mahajan, Annil Khajuria, Vijay Mahajan, Vivek Prakash, Chander J Midlife Health Original Article AIM OF STUDY: The aim of this study is to evaluate antihypertensive drug prescription patterns, rationality and adherence to Joint National Committee (JNC-7) hypertension (HT) treatment recommendations among Indian postmenopausal women (PMW). MATERIALS AND METHODS: An observational and cross-sectional prospective prescription audit study was carried over a period of 1 year. A total of 500 prescriptions prescribed to PMW for diagnosed HT, were identified for one point analysis. Drug prescription patterns/trends, and their adherence to JNC-7 report as well as rationality using WHO guide to good prescribing was assessed. RESULTS: In the monotherapy, category angiotensin receptor blockers (ARBs) accounted (24.8%), calcium channel blockers (CCBs) (19.4%), angiotensin converting enzyme inhibitors (ACEIs) (11%), beta blockers (BBs) (2.8%), and diuretics (2%) of the total prescription. Individually, amlodipine was maximally prescribed in 16.4%. 31.6% had double combination, whereas 2.2% and 1% had triple and four drug combinations, respectively. About 3.6% of the prescription contained antihypertensive combination along with other class of drug. ARBs + diuretic were observed in 11%, CCBs + BB 10% and ACEI + diuretic in 2.6% of the total prescriptions. Among the combination therapy amlodipine + atenolol (8.4%), telmisartan + hydrochlorothiazide (6%) and losartan + hydrochlorothiazide (4.4%) were maximally prescribed. 84.21% (P < 0.001) of the prescription showed nonadherence as per recommendations for pre-HT. 100% and 43.25% adherence rates were noticed for Stage 1 HT (P < 0.001) and Stage 2 HT (P > 0.05) patients. CONCLUSION: Antihypertensive prescription trends largely adhere to existing guidelines and are rational except polypharmacy, generic and fixed dose combinations prescribing, were some of the common pharmacologically considered irrationality noticed. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4071649/ /pubmed/24970986 http://dx.doi.org/10.4103/0976-7800.133994 Text en Copyright: © Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Tandon, Vishal R. Sharma, Sudhaa Mahajan, Shagun Mahajan, Annil Khajuria, Vijay Mahajan, Vivek Prakash, Chander Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women |
title | Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women |
title_full | Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women |
title_fullStr | Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women |
title_full_unstemmed | Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women |
title_short | Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women |
title_sort | antihypertensive drug prescription patterns, rationality, and adherence to joint national committee-7 hypertension treatment guidelines among indian postmenopausal women |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071649/ https://www.ncbi.nlm.nih.gov/pubmed/24970986 http://dx.doi.org/10.4103/0976-7800.133994 |
work_keys_str_mv | AT tandonvishalr antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen AT sharmasudhaa antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen AT mahajanshagun antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen AT mahajanannil antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen AT khajuriavijay antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen AT mahajanvivek antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen AT prakashchander antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen |